367 related articles for article (PubMed ID: 20233996)
1. Gene expression-based prognostic signatures in lung cancer: ready for clinical use?
Subramanian J; Simon R
J Natl Cancer Inst; 2010 Apr; 102(7):464-74. PubMed ID: 20233996
[TBL] [Abstract][Full Text] [Related]
2. Re: Gene expression-based prognostic signatures in lung cancer: ready for clinical use?
Boutros PC; Pintilie M; John T; Starmans MH; Der SD; Shepherd FA; Tsao MS; Jurisica I
J Natl Cancer Inst; 2010 Nov; 102(21):1677-8; author reply 1678-9. PubMed ID: 20921041
[No Abstract] [Full Text] [Related]
3. Gene profiling of clinical routine biopsies and prediction of survival in non-small cell lung cancer.
Baty F; Facompré M; Kaiser S; Schumacher M; Pless M; Bubendorf L; Savic S; Marrer E; Budach W; Buess M; Kehren J; Tamm M; Brutsche MH
Am J Respir Crit Care Med; 2010 Jan; 181(2):181-8. PubMed ID: 19833826
[TBL] [Abstract][Full Text] [Related]
4. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.
Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX
Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742
[TBL] [Abstract][Full Text] [Related]
5. Is gene array testing to be considered routine now?
Paik S
Breast; 2011 Oct; 20 Suppl 3():S87-91. PubMed ID: 22015300
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling of non-small-cell lung cancer.
Lacroix L; Commo F; Soria JC
Expert Rev Mol Diagn; 2008 Mar; 8(2):167-78. PubMed ID: 18366303
[TBL] [Abstract][Full Text] [Related]
7. Understanding prognostic gene expression signatures in lung cancer.
Zhu CQ; Pintilie M; John T; Strumpf D; Shepherd FA; Der SD; Jurisica I; Tsao MS
Clin Lung Cancer; 2009 Sep; 10(5):331-40. PubMed ID: 19808191
[TBL] [Abstract][Full Text] [Related]
8. Genomic signatures individualize therapeutic decisions in non-small-cell lung cancer.
Anguiano A; Potti A
Expert Rev Mol Diagn; 2007 Nov; 7(6):837-44. PubMed ID: 18020912
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiles in esophageal adenocarcinoma predict survival after resection.
Pennathur A; Xi L; Litle VR; Gooding WE; Krasinskas A; Landreneau RJ; Godfrey TE; Luketich JD
J Thorac Cardiovasc Surg; 2013 Feb; 145(2):505-12; discussion 512-3. PubMed ID: 23321130
[TBL] [Abstract][Full Text] [Related]
10. Personalized peptide vaccination in patients with refractory non-small cell lung cancer.
Yoshiyama K; Terazaki Y; Matsueda S; Shichijo S; Noguchi M; Yamada A; Mine T; Ioji T; Itoh K; Shirouzu K; Sasada T; Takamori S
Int J Oncol; 2012 May; 40(5):1492-500. PubMed ID: 22307435
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
12. Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays.
Albain KS; Paik S; van't Veer L
Breast; 2009 Oct; 18 Suppl 3():S141-5. PubMed ID: 19914534
[TBL] [Abstract][Full Text] [Related]
13. Prognostic score for second-line chemotherapy of advanced non-small-cell lung cancer: external validation in a phase III trial comparing vinflunine with docetaxel.
Di Maio M; Krzakowski M; Fougeray R; Kowalski DM; Gridelli C
Lung Cancer; 2012 Jul; 77(1):116-20. PubMed ID: 22361218
[TBL] [Abstract][Full Text] [Related]
14. Absence of prognostic significance of p21(WAF1/CIP1) protein expression in non-small cell lung cancer.
Dworakowska D; Jassem E; Jassem J; Boltze C; Wiedorn KH; Dworakowski R; Skokowski J; Jaśkiewicz K; Czestochowska E
Acta Oncol; 2005; 44(1):75-9. PubMed ID: 15848909
[TBL] [Abstract][Full Text] [Related]
15. Cancer adjuvant chemotherapy strategic classification by artificial neural network with gene expression data: An example for non-small cell lung cancer.
Chen YC; Chang YC; Ke WC; Chiu HW
J Biomed Inform; 2015 Aug; 56():1-7. PubMed ID: 25998519
[TBL] [Abstract][Full Text] [Related]
16. Integrated gene expression profile predicts prognosis of breast cancer patients.
Li LF; Xu XJ; Zhao Y; Liu ZB; Shen ZZ; Jin WR; Shao ZM
Breast Cancer Res Treat; 2009 Jan; 113(2):231-7. PubMed ID: 18278552
[TBL] [Abstract][Full Text] [Related]
17. Chondrolectin is a novel diagnostic biomarker and a therapeutic target for lung cancer.
Masuda K; Takano A; Oshita H; Akiyama H; Tsuchiya E; Kohno N; Nakamura Y; Daigo Y
Clin Cancer Res; 2011 Dec; 17(24):7712-22. PubMed ID: 22016508
[TBL] [Abstract][Full Text] [Related]
18. A prognostic test for adenocarcinoma of the lung from gene expression profiling data.
Gordon GJ; Richards WG; Sugarbaker DJ; Jaklitsch MT; Bueno R
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):905-10. PubMed ID: 14504202
[TBL] [Abstract][Full Text] [Related]
19. Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types.
Starmans MH; Krishnapuram B; Steck H; Horlings H; Nuyten DS; van de Vijver MJ; Seigneuric R; Buffa FM; Harris AL; Wouters BG; Lambin P
Br J Cancer; 2008 Dec; 99(11):1884-90. PubMed ID: 18985037
[TBL] [Abstract][Full Text] [Related]
20. Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer.
Krebs MG; Sloane R; Priest L; Lancashire L; Hou JM; Greystoke A; Ward TH; Ferraldeschi R; Hughes A; Clack G; Ranson M; Dive C; Blackhall FH
J Clin Oncol; 2011 Apr; 29(12):1556-63. PubMed ID: 21422424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
